Sigilon Therapeutics, Inc. Debt to Equity Ratio 2021-2023 | SGTX
Current and historical debt to equity ratio values for Sigilon Therapeutics, Inc. (SGTX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Sigilon Therapeutics, Inc. debt/equity for the three months ending June 30, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-06-30 | $0.03B | $0.03B | 1.02 |
| 2023-03-31 | $0.04B | $0.03B | 1.30 |
| 2022-12-31 | $0.05B | $0.04B | 1.23 |
| 2022-09-30 | $0.05B | $0.04B | 1.13 |
| 2022-06-30 | $0.06B | $0.05B | 1.07 |
| 2022-03-31 | $0.06B | $0.07B | 0.95 |
| 2021-12-31 | $0.07B | $0.08B | 0.87 |
| 2021-09-30 | $0.07B | $0.09B | 0.76 |
| 2021-06-30 | $0.08B | $0.11B | 0.68 |
| 2021-03-31 | $0.07B | $0.13B | 0.58 |
| 2020-12-31 | $0.08B | $0.15B | 0.54 |
| 2020-09-30 | $0.00B | 0.00 | |
| 2020-06-30 | $0.00B | 0.00 | |
| 2020-03-31 | $0.00B | 0.00 | |
